Lithuania - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Lithuania Hospital Average Length of Stay for Malignant Neoplasm of Prostate decreased by 1.6% year on year. With 10.8 Days in 2019, the country was number 3 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate. Lithuania is overtaken by New Zealand, which was number 2 at 11.6 Days and is followed by Slovakia with 10.5 Days. South Korea ranked the highest with 15.9 Days in 2019, that is stable compared to 2018. New Zealand witnessed the best average annual growth at +2.2% per year, while Mexico recorded the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 10.80 |
| 2018 | 11.00 |
| 2017 | 10.80 |
| 2016 | 10.70 |
| 2015 | 12.20 |
Download all data from 2012 to 2019
How does Lithuania rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data |
| 3 |
#3
Lithuania
|
10.80 | 2019 | -1.8 % | -1.6 % | View data |
| 4 |
#4
Germany
|
10.50 | 2019 | -0.9 % | -1.3 % | View data |
| 4 |
#4
Slovakia
|
10.50 | 2019 | -0.9 % | +0.2 % | View data |